SPONSOR
Shandong Cancer Hospital and Institute
Total Trials
3
Recruiting
3
Phases
Phase 2
Conditions studied: Endometrial NeoplasmsNeoplasm Recurrence, LocalNeoplasm MetastasisRectal Malignant NeoplasmsPancreas Cancer
Shandong Cancer Hospital and Institute is a clinical research sponsor with 3 registered studies on ClinicalTrials.gov, of which 3 are actively recruiting participants. Research covers conditions including Endometrial Neoplasms, Neoplasm Recurrence, Local, Neoplasm Metastasis, Rectal Malignant Neoplasms.
The trial portfolio spans Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Shandong Cancer Hospital and Institute
How many clinical trials has Shandong Cancer Hospital and Institute sponsored?
ClinicalMetric currently tracks 3 clinical trials sponsored by Shandong Cancer Hospital and Institute, of which 3 are actively recruiting participants. These trials cover conditions including Endometrial Neoplasms, Neoplasm Recurrence, Local, Neoplasm Metastasis. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Shandong Cancer Hospital and Institute research focus on?
Shandong Cancer Hospital and Institute clinical trials span Endometrial Neoplasms, Neoplasm Recurrence, Local, Neoplasm Metastasis, Rectal Malignant Neoplasms, Pancreas Cancer. The research pipeline includes Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Shandong Cancer Hospital and Institute clinical trial?
To participate in a Shandong Cancer Hospital and Institute trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Shandong Cancer Hospital and Institute trials with current recruitment status updated daily.
Clinical Trials by Shandong Cancer Hospital and Institute
NCT06532539 Phase 2
Recruiting
Cadonilimab With Chemoradiation for Recurrent and Oligometastatic Endometrial Carcinoma
Endometrial Neoplasms
NCT07026422 Phase 2
Recruiting
Iparomlimab/Tuvonralimab Integrating With Total Neoadjuvant Therapy for pMMR/MSS Locally Advanced Rectal Cancer (IT-TNT)
Rectal Malignant Neoplasms
NCT06050317 Phase 2
Recruiting
Sintilimab Combined With Chemotherapy and Radiotherapy in Patients With Inoperable Pancreatic Cancer
Pancreas Cancer
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology